Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Anaheim. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Anaheim at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
Pfizer MEVPRO-1 (C2321014) is a randomized, open-label, multi-center clinical trial evaluating whether combining the study medicine (PF-06821497) with enzalutamide is safe and effective compared to physician's choice of either second-line androgen receptor (AR) directed therapy with enzalutamide or docetaxel (chemotherapy) for treating metastatic castration-resistant prostate cancer (mCRPC) after progression on prior abiraterone acetate treatment. The primary objective of this clinical trial is
Sponsor: Pfizer
Check if you qualify for this prostate cancer clinical trial in Anaheim, CA
If you're searching for prostate cancer treatment options in Anaheim, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anaheim research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.